AzTrials
AzTrials

HealthyEarly Phase 1NCT01038934

DNA of Oral Cytobrush in Three Means Conservation

A Early Phase 1 study testing samples collected by buccal cytobrush in people with Healthy, run by UPECLIN HC FM Botucatu Unesp at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to analyze genomic DNA of buccal cytobrush stored in three means conservation. Read more about this study

Who is it for?
Ages 20 to 33 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
samples collected by buccal cytobrush
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteBrazil
Study dates
Mar 2006to Dec 2009
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 33 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy young

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • School of Dentistry, Sao Paulo State University, Unesp, Araçatuba/SP

    Araçatuba, São Paulo

Other trials in Brazil

About this study

Official title: Evaluation of Genomic DNA of Oral Cytobrush in Three Means Conservation

The aim of this study is to analyze genomic DNA of buccal cytobrush stored in three means conservation.

Read the detailed description

Blood samples are an excellent source of large amounts of genomic DNA. However, alternative sources are often needed in epidemiological studies because of difficulties in obtaining blood samples.

Conditions
Healthy
Being tested
samples collected by buccal cytobrush
Keywords
Buccal Mucosa, DNA, Polymerase Chain Reaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • samples collected by buccal cytobrushProcedure or surgery

Study groups in NCT01038934
Study groupRoleWhat they receive
buccal cytobrhshExperimentalhealthy young
Receives: Procedure: samples collected by buccal cytobrush

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2009 (estimated)
  2. Study startMar 2006
  3. Primary completionDec 2009
  4. Study completionDec 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01038934
Sponsor's protocol ID
upeclin/FOA-Unesp-04
Status last verified
Dec 2009
First submitted
22 Dec 2009
Last updated
24 Dec 2009
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing samples collected by buccal cytobrush in people with Healthy, run by UPECLIN HC FM Botucatu Unesp at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Dec 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in